摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+/-)-1-[3-[[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl](phenylmethyl)amino]-2-hydroxypropyl]tetrahydro-2(1H)pyrimidinone | 312933-45-2

中文名称
——
中文别名
——
英文名称
(+/-)-1-[3-[[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl](phenylmethyl)amino]-2-hydroxypropyl]tetrahydro-2(1H)pyrimidinone
英文别名
1-[3-[benzyl(3,4-dihydro-2H-chromen-2-ylmethyl)amino]-2-hydroxypropyl]-1,3-diazinan-2-one
(+/-)-1-[3-[[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl](phenylmethyl)amino]-2-hydroxypropyl]tetrahydro-2(1H)pyrimidinone化学式
CAS
312933-45-2
化学式
C24H31N3O3
mdl
——
分子量
409.528
InChiKey
WZBWBFVKGWDNRB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    30
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    65
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
    申请人:Van Emelen Kristof
    公开号:US20050096378A1
    公开(公告)日:2005-05-05
    The present invention concerns compounds of formula (I) a stereochemically isomeric form thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, wherein -Z 1 -Z 2 - is a bivalent radical; R 1 , R 2 and R 3 are each independently selected from hydrogen, C 1-6 alkyl, hydroxy, halo and the like; or when R 1 and R 2 are on adjacent carbon atoms, R 1 and R 2 taken together may form a bivalent radical of formula; Alk 1 and Alk 2 are optionally substituted C 1-6 alkanediyl; R 6 is hydrogen or phenylmethyl; R 5 is a radical of formula wherein n is 1 or 2; p 1 is 0, and p 2 is 1 or 2; or p 1 is 1 or 2, and p 2 is 0; X is oxygen, sulfur or ═NR 9 ; Y is oxygen or sulfur; R 7 is hydrogen, C 1-6 alkyl, C 3-6 cycloalkyl, phenyl or phenylmethyl; R 8 is C 1-6 alkyl, C 3-6 cycloalkyl phenyl or phenylmethyl; R 9 is cyano, C 1-6 alkyl, C 3-6 cyclo-alkyl, C 1-6 alkyloxycarbonyl or aminocarbonyl; R 10 is hydrogen or C 1-6 alkyl; and Q is a bivalent radical. Processes for preparing said products, formulations comprising said products and their use as a medicine are disclosed, in particular for treating conditions which are related to impaired fundic relaxation.
    本发明涉及式(I)的化合物,其立体化学异构体形式,其N-氧化物形式或其药学上可接受的酸加合盐,其中-Z1-Z2-是二价基团;R1,R2和R3分别独立地选择自氢,C1-6烷基,羟基,卤素等;或当R1和R2在相邻碳原子上时,R1和R2结合在一起可以形成式的二价基团;Alk1和Alk2是可选择的取代的C1-6烷二基基团;R6是氢或苯甲基;R5是式其中n为1或2;p1为0,p2为1或2;或p1为1或2,p2为0;X是氧,硫或═NR9;Y是氧或硫;R7是氢,C1-6烷基,C3-6环烷基,苯基或苯甲基;R8是C1-6烷基,C3-6环烷基,苯基或苯甲基;R9是氰基,C1-6烷基,C3-6环烷基,C1-6烷氧基羰基或氨基羰基;R10是氢或C1-6烷基;Q是二价基团。公开了制备所述产品的方法,包括所述产品的配方以及其作为药物的用途,特别是用于治疗与胃底松弛受损相关的疾病。
  • US6864273B1
    申请人:——
    公开号:US6864273B1
    公开(公告)日:2005-03-08
  • US7273862B2
    申请人:——
    公开号:US7273862B2
    公开(公告)日:2007-09-25
  • AMINOALKYL SUBSTITUTED (BENZODIOXAN, BENZOFURAN OR BENZOPYRAN) DERIVATIVES
    申请人:Janssen Pharmaceutica N.V.
    公开号:EP1187829B1
    公开(公告)日:2003-12-10
查看更多